Email this article to a friend
Drotrecogin alfa (activated) in patients with severe sepsis and a high risk of death
-
* Corresponding author: Jan O Friedrich j.friedrich@utoronto.ca
Critical Care 2006, 10:427 doi:10.1186/cc5117